Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding
213,001,347
Total 13F shares
17,647,287
Share change
+3,227,743
Total reported value
$699,362,453
Price per share
$41.57
Number of holders
48
Value change
+$105,685,176
Number of buys
26
Number of sells
13

Security key

86366E106

Report period

Q2 2023

Institutions

48

Top holders

10

Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Deep Track Capital, LP
13F
Company
1.2%
2,646,782
$62,966,936 31 Mar 2023
13F
BVF INC/IL
13F
Company
0.82%
1,750,000
$41,632,500 31 Mar 2023
13F
FMR LLC
13F
Company
0.59%
1,249,426
$29,723,844 31 Mar 2023
13F
FEDERATED HERMES, INC.
13F
Company
0.49%
1,052,802
$25,046,160 31 Mar 2023
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.44%
940,228
$22,368,024 31 Mar 2023
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.37%
786,505
$18,711,000 31 Mar 2023
13F
Ramy Farid
3/4/5
Director
mixed-class rows
3,535,495
mixed-class rows
$17,176,500 07 Feb 2023
Casdin Capital, LLC
13F
Company
0.32%
677,017
$16,106,234 31 Mar 2023
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.28%
598,108
$14,229,000 31 Mar 2023
13F
Cormorant Asset Management, LP
13F
Company
0.27%
576,373
$13,712,000 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0.19%
400,000
$9,516,000 31 Mar 2023
13F
JENNISON ASSOCIATES LLC
13F
Company
0.19%
399,780
$9,510,766 31 Mar 2023
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.18%
375,000
$8,921,250 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.17%
366,287
$8,713,967 31 Mar 2023
13F
Logos Global Management LP
13F
Company
0.16%
350,000
$8,326,500 31 Mar 2023
13F
TCG Crossover Management, LLC
13F
Company
0.16%
350,000
$8,326,500 31 Mar 2023
13F
Point72 Asset Management, L.P.
13F
Company
0.16%
349,862
$8,323,217 31 Mar 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.15%
325,000
$7,731,750 31 Mar 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.14%
292,398
$6,956,148 31 Mar 2023
13F
Monashee Investment Management LLC
13F
Company
0.08%
170,000
$4,044,300 31 Mar 2023
13F
Woodline Partners LP
13F
Company
0.08%
170,000
$4,044,300 31 Mar 2023
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.16%
346,421
$3,289,806 31 Mar 2023
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.05%
99,899
$2,376,597 31 Mar 2023
13F
Octagon Capital Advisors LP
13F
Company
0.04%
93,692
$2,228,933 31 Mar 2023
13F
Artal Group S.A.
13F
Company
0.04%
75,000
$1,784,000 31 Mar 2023
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.02%
50,000
$1,189,500 31 Mar 2023
13F
Nantahala Capital Management, LLC
13F
Company
0.02%
50,000
$1,189,500 31 Mar 2023
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.02%
42,000
$999,180 31 Mar 2023
13F
TD ASSET MANAGEMENT INC
13F
Company
0.02%
35,946
$855,155 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
35,459
$844,000 31 Mar 2023
13F
SVB FINANCIAL GROUP
13F
Company
0.02%
35,353
$841,048 31 Mar 2023
13F
Lynx1 Capital Management LP
13F
Company
0.01%
23,000
$547,170 31 Mar 2023
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.01%
22,050
$524,570 31 Mar 2023
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.01%
15,000
$356,850 31 Mar 2023
13F
Middle East Fze Point72
13F
Individual
0%
8,474
$201,596 31 Mar 2023
13F
Melita Sun Jung
3/4/5
Chief Business Officer
class O/S missing
1,000
$62,460 07 Feb 2023
Cubist Systematic Strategies, LLC
13F
Company
0%
805
$19,151 31 Mar 2023
13F
SIGNATUREFD, LLC
13F
Company
0%
100
$2,379 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
100
$2,000 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0%
11
$262 31 Mar 2023
13F
FIL Ltd
3/4/5
Other*
class O/S missing
6,473,761
07 Feb 2023
BVF PARTNERS L P/IL
3/4/5
10%+ Owner
class O/S missing
462,605
10 May 2023

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q2 2023

As of 30 Jun 2023, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,647,287 shares. The largest 10 holders included Deep Track Capital, LP, PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, Monashee Investment Management LLC, FMR LLC, Driehaus Capital Management LLC, FEDERATED HERMES, INC., Casdin Capital, LLC, T. Rowe Price Investment Management, Inc., and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 48 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
38
Q2 2023 holders
48
Holder diff
10
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .